Alleviare India Logo

Polivy Polatuzumab Vedotin 140mg Injection

Polivy (polatuzumab vedotin-piiq) is a medication used to treat certain types of non-Hodgkin’s lymphoma. It is classified as an antibody-drug conjugate, which means it combines a monoclonal antibody with a chemotherapy drug. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.

Polivy (Polatuzumab Vedotin) is a prescription medicine used to treat a specific type of non-Hodgkin’s lymphoma (NHL) known as diffuse large B-cell lymphoma (DLBCL) that has relapsed or is refractory (did not respond to previous treatment). Polivy is an antibody-drug conjugate that works by binding to a protein called CD79b on the surface of cancer cells and delivering a toxic substance to kill the cancer cells.

Polivy (Polatuzumab Vedotin) is a prescription medicine used to treat a specific type of non-Hodgkin’s lymphoma (NHL) known as diffuse large B-cell lymphoma (DLBCL) that has relapsed or is refractory (did not respond to previous treatment). Polivy is an antibody-drug conjugate that works by binding to a protein called CD79b on the surface of cancer cells and delivering a toxic substance to kill the cancer cells.

Polivy (polatuzumab vedotin-piiq) suppliers in India: Alleviare India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specializing in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of the latest medicines that are available in countries of Europe and USA.

The order for Polivy (polatuzumab vedotin-piiq) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Polivy (Polatuzumab Vedotin) is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in combination with other chemotherapy medicines, such as bendamustine and rituximab.

Medicine Name: Polivy

Generic Name: Polatuzumab Vedotin-piiq
Approval Date: June 10, 2019

Company Name: Genentech Inc.

Polivy (polatuzumab vedotin-piiq) is available.

Get In Touch

    Polivy (polatuzumab vedotin-piiq) suppliers in India

    ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Polivy (polatuzumab vedotin-piiq) on prescription and Import License in Patient’s Name only.

    For foreign countries patients, Polivy (polatuzumab vedotin-piiq) can be made available in Send your inquiry to find Polivy (polatuzumab vedotin-piiq) in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

    News / Update for Polivy (polatuzumab vedotin-piiq)

    For Polivy (polatuzumab vedotin-piiq) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details